Classifications

• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
  • C12N9/0004—Oxidoreductases (1.)
  • C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
  • C12P19/00—Preparation of compounds containing saccharide radicals
  • C12P19/02—Monosaccharides
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
  • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
  • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
  • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
  • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
  • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
  • C12N11/082—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
  • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
  • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
  • C12N11/082—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds
  • C12N11/087—Acrylic polymers
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
  • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
  • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
  • C12N11/089—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
  • C12N11/091—Phenol resins; Amino resins
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
  • C12N11/14—Enzymes or microbial cells immobilised on or in an inorganic carrier
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
  • C12N9/10—Transferases (2.)
  • C12N9/1048—Glycosyltransferases (2.4)
  • C12N9/1051—Hexosyltransferases (2.4.1)
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
  • C12N9/10—Transferases (2.)
  • C12N9/1048—Glycosyltransferases (2.4)
  • C12N9/1051—Hexosyltransferases (2.4.1)
  • C12N9/107—1,4-Alpha-glucan branching enzyme (2.4.1.18)
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
  • C12N9/14—Hydrolases (3)
  • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
  • C12N9/14—Hydrolases (3)
  • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
  • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
  • C12N9/2405—Glucanases
  • C12N9/2451—Glucanases acting on alpha-1,6-glucosidic bonds
  • C12N9/246—Isoamylase (3.2.1.68)
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
  • C12N9/88—Lyases (4.)
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
  • C12N9/90—Isomerases (5.)
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
  • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
  • C12P19/00—Preparation of compounds containing saccharide radicals
  • C12P19/18—Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
  • C12P19/00—Preparation of compounds containing saccharide radicals
  • C12P19/24—Preparation of compounds containing saccharide radicals produced by the action of an isomerase, e.g. fructose
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Y—ENZYMES
  • C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
  • C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
  • C12Y101/01017—Mannitol-1-phosphate 5-dehydrogenase (1.1.1.17)
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Y—ENZYMES
  • C12Y204/00—Glycosyltransferases (2.4)
  • C12Y204/01—Hexosyltransferases (2.4.1)
  • C12Y204/01001—Phosphorylase (2.4.1.1)
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Y—ENZYMES
  • C12Y204/00—Glycosyltransferases (2.4)
  • C12Y204/01—Hexosyltransferases (2.4.1)
  • C12Y204/01018—1,4-Alpha-glucan branching enzyme (2.4.1.18), i.e. glucan branching enzyme
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Y—ENZYMES
  • C12Y204/00—Glycosyltransferases (2.4)
  • C12Y204/01—Hexosyltransferases (2.4.1)
  • C12Y204/01025—4-Alpha-glucanotransferase (2.4.1.25)
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Y—ENZYMES
  • C12Y301/00—Hydrolases acting on ester bonds (3.1)
  • C12Y301/03—Phosphoric monoester hydrolases (3.1.3)
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Y—ENZYMES
  • C12Y401/00—Carbon-carbon lyases (4.1)
  • C12Y401/02—Aldehyde-lyases (4.1.2)
  • C12Y401/0204—Tagatose-bisphosphate aldolase (4.1.2.40)
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Y—ENZYMES
  • C12Y501/00—Racemaces and epimerases (5.1)
  • C12Y501/03—Racemaces and epimerases (5.1) acting on carbohydrates and derivatives (5.1.3)
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Y—ENZYMES
  • C12Y503/00—Intramolecular oxidoreductases (5.3)
  • C12Y503/01—Intramolecular oxidoreductases (5.3) interconverting aldoses and ketoses (5.3.1)
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Y—ENZYMES
  • C12Y503/00—Intramolecular oxidoreductases (5.3)
  • C12Y503/01—Intramolecular oxidoreductases (5.3) interconverting aldoses and ketoses (5.3.1)
  • C12Y503/01009—Glucose-6-phosphate isomerase (5.3.1.9)
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Y—ENZYMES
  • C12Y504/00—Intramolecular transferases (5.4)
  • C12Y504/02—Phosphotransferases (phosphomutases) (5.4.2)
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Y—ENZYMES
  • C12Y504/00—Intramolecular transferases (5.4)
  • C12Y504/02—Phosphotransferases (phosphomutases) (5.4.2)
  • C12Y504/02002—Phosphoglucomutase (5.4.2.2)
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Y—ENZYMES
  • C12Y504/00—Intramolecular transferases (5.4)
  • C12Y504/02—Phosphotransferases (phosphomutases) (5.4.2)
  • C12Y504/02006—Beta-phosphoglucomutase (5.4.2.6)
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Y—ENZYMES
  • C12Y504/00—Intramolecular transferases (5.4)
  • C12Y504/02—Phosphotransferases (phosphomutases) (5.4.2)
  • C12Y504/02008—Phosphomannomutase (5.4.2.8)
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
  • C12R2001/00—Microorganisms ; Processes using microorganisms
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Y—ENZYMES
  • C12Y204/00—Glycosyltransferases (2.4)
  • C12Y204/01—Hexosyltransferases (2.4.1)
  • C12Y204/01024—1,4-Alpha-glucan 6-alpha-glucosyltransferase (2.4.1.24)
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Y—ENZYMES
  • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
  • C12Y207/01—Phosphotransferases with an alcohol group as acceptor (2.7.1)
  • C12Y207/01144—Tagatose-6-phosphate kinase (2.7.1.144)
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Y—ENZYMES
  • C12Y501/00—Racemaces and epimerases (5.1)
  • C12Y501/03—Racemaces and epimerases (5.1) acting on carbohydrates and derivatives (5.1.3)
  • C12Y501/03015—Glucose-6-phosphate 1-epimerase (5.1.3.15)

Definitions

• the invention relates to preparation of hexose monosaccharides using immobilized enzyme compositions. More specifically, the invention relates to methods of preparing a D-hexose (or hexose) from saccharides (e.g., polysaccharides, oligosaccharides, disaccharides, sucrose, D-glucose, and D- fructose) including a step in which fructose 6-phosphate is converted to the hexose by one or more enzymatic steps catalyzed by immobilized enzymes.
• saccharides e.g., polysaccharides, oligosaccharides, disaccharides, sucrose, D-glucose, and D- fructose
• Hexoses are monosaccharides with six carbon atoms. Hexoses include, for example, tagatose, psicose, fructose, allose, mannose, galactose, altrose, talose, sorbose, gulose, idose, and inositol. Hexoses are used in numerous industries, clearly having a variety of applications in the pharmaceutical industry, biotechnology, and in the food and beverage industries. Hexoses may be prepared using enzymatic processes from saccharides, such as for example, monosaccharides, oligsaccharides, starch, starch derivatives, cellulose and the like. Solution-based enzymatic processes are described in published PCT applications WO 2018/169957, WO 2017/059278, and WO 2018/112139, which are incorporated herein by reference.
• the enzymes in commercial processes can be adsorbed on insoluble organic or inorganic supports commonly used to improve functionality, as known in the art. These include polymeric supports such as agarose, methacrylate, polystyrene, phenol formaldehyde, or dextran, as well as inorganic supports such as glass, metal, or carbon-based materials. These materials are often produced with large surface-to-volume ratios and specialized surfaces that promote attachment and activity of immobilized enzymes. The enzymes might be affixed to these solid supports through covalent, ionic, or hydrophobic interactions.
• the enzymes could also be affixed through genetically engineered interactions such as covalent fusion to another protein or peptide sequence with affinity to the solid support, most often a polyhistidine sequence.
• the enzymes might be affixed either directly to the surface or surface coating, or they might be affixed to other proteins already present on the surface or surface coating.
• the enzymes can be immobilized all on one carrier, on individual carriers, or a combination of the two (e.g., two enzyme per carrier then mix those carriers). These variations can be mixed evenly or in defined layers to optimize turnover in a continuous reactor. These enzymes may be mixed evenly or in defined layers or zones to optimize turnover. For example, the beginning of the reactor may have a layer of aGP to ensure a high initial G1P increase.
• Enzymes may be immobilized all on one carrier bead, each on an individual carrier bead, or in groups of enzymes on a carrier bead. Similarly the enzymes may be immobilized on a specific carrier or multiple carriers within one process using one or more immobilization methodologies.
• the invention relates to immobilized enzyme compositions for the preparation of a hexose.
• Hexoses include, for example, tagatose, psicose, fructose, allose, mannose, galactose, altrose, talose, sorbose, gulose, idose, and inositol.
• An immobilized enzyme composition of the invention comprises, consists essentially of, or consists of at least two, at least three, at least four, at least five, at least six carriers, at least seven, or at least eight of the following enzymes immobilized to at least one carrier or a mixture of carriers:
• aGP glucan phosphorylase
• PGM phosphoglucomutase
• 4-GT 1,4-glucan transferase
• phosphoglucoisomerase (i) phosphoglucoisomerase (PGI), fructose-6-phosphate epimerase (F6PE), and tagatose-6-phosphate phosphatase (T6PP) to prepare tagatose; (ii) phosphoglucoisomerase (PGI), piscose-6-phosphate epimerase (P6PE), and picose-6-phosphate phosphatase (P6PP) to prepare allulose;
• phosphoglucoisomerase P6PE
• allose-6-phosphate isomerase A6PI
• allose-6-phosphate phosphatase A6PP
• phosphoglucoisomerase PGI
• M6PI mannose-6-phosphate isomerase
• PGPMI phosphoglucose/phosphomannose isomerase
• M6PP mannose 6-phosphate phosphatase
• inositol 3-phosphate synthase (IPS) and inositol monophosphatase (IMP) to prepare inositol.
• the weight of each enzyme relative to the total weight of the enzymes (w/w)% ranges from 0.1% to 40%.
• the invention also relates to an enzymatic process for preparing a hexose from a saccharide by contacting a starch derivative with an immobilized enzyme composition of the invention under suitable reaction conditions convert the starch derivative to the hexose.
• FIG. 1A is a graph showing the amounts of enzyme in an immobilized enzyme composition that is optimized for tagatose production.
• FIG. IB is a graph showing the amounts of enzyme in an immobilized enzyme composition in which the amounts are normalized based on the observed reaction rate of each enzyme relative to T6PP activity in order to have equal units of activity within the cascade.
• FIG. 1C is a graph showing the amounts of enzyme in an immobilized enzyme composition in which the amounts were in w/w ratios of 1:1:1:1:1:1.
• FIG. 2 is a graph showing the relationship of enzyme loading (w/w% of total enzyme weight/carrier weight) on the activity of an immobilized enzyme composition that is optimized for tagatose production on DUOLITETM A568. Results shown are based on relative enzymatic cascade rates with respect to a 5% loaded carrier.
• the following description discloses the invention according to embodiments related to making and using enzymes that are immobilized to a carrier ("immobilized enzyme compositions") in processes for converting starches and starch derivatives and saccharides to hexose monosaccharides, including, for example, tagatose, psicose, fructose, allose, mannose, galactose, altrose, talose, sorbose, gulose, idose, and inositol.
• These processes can generally be described as enzymatic reactions that create a phosphorylated intermediate from starch, a starch derivative, or a saccharide using free phosphate (no ATP).
• the free phosphate is released in a highly energetically favorable final step to produce a hexose-of-interest (e.g., tagatose, psicose, fructose, allose, mannose, galactose, altrose, talose, sorbose, gulose, idose, or inositol).
• a hexose- of-interest e.g., tagatose, psicose, fructose, allose, mannose, galactose, altrose, talose, sorbose, gulose, idose, or inositol.
• the phosphate is then recycled to convert additional starch, starch derivative, or a saccharide into a phosphorylated intermediate so that the process can repeat. This allows for non- stoichiometric amounts of phosphate to be utilized which lowers the cost of phosphate use in the process and limits phosphate
• Embodiments of the invention include compositions of at least two, at least three, at least four, at least five, at least six carriers, at least seven, or at least eight enzymes, that are immoblized on a carrier, and, which catalyze, respectively, reactions in an enzymatic process for converting a starch, starch derivative, and/or a saccharide to a hexose.
• An immobilized enzyme composition of the invention provides numerous advantages over their use in free solution, including: longer duration of activity (due to protection of structural features of the protein), multiple cycle reuse, and elimination of the need to remove the enzyme downstream.
• immobilizing enzymes on solid surfaces can work in either a stirred tank reactor, a packed bed reactor, or a rotating bed reactor; allowing flexibility in scale-up.
• the enzymes contained in an immobilzed enzyme composition of the invention catalyze at least two, at least three, at least four, at least five, at least six carriers, at least seven, or at least eight, reactions involved in the stepwise conversion of a starch, starch derivative, or saccharides to a hexose.
• the following patent publications which are all disclosed herein in their entireties, disclose enzymatic processes, (i.e., enzyme reaction cascades) for producing hexoses in solution: published PCT applications WO 2018/169957, WO 2017/059278, and WO 2018/112139.
• Immobilized enzyme compositions of the invention can include, but are not limited to, any of the enzymes and enzyme combinations disclosed in these references.
• Some immobilized enzyme compositions of the invention contain a combination of enzymes that catalyze reactions, which are common among processes for producing different hexoses, such as reaction steps leading to conversion of glucose 6-phosphate (G6P) to fructose 6-phosphate (F6P).
• the enzymes that catalyze these common reaction steps may be referred to as "core enzymes”.
• an immobilized enzyme composition at least contains the core enzymes, a glucan phosphorylase (aGP) to convert a saccharide to glucose 1-phosphate (G1P) and phosphoglucomutase (PGM) to convert G1P to glucose 6-phosphate (G6P).
• aGP glucan phosphorylase
• PGM phosphoglucomutase
• Enzymes in an immobilized enzyme composition of the invention, which catalyze additional reaction steps to convert G6P to various hexose products can be coimmobilized with core enzymes, or contained in separate immobilized enzyme compositions.
• core enzymes are combined in an immobilized composition with one or more of enzymes used in the production of tagatose, psicose, fructose, allose, mannose, galactose, altrose, talose, sorbose, gulose, idose, or inositol.
• some immobilized enzyme compositions according to the invention also contain: (i) phosphoglucoisomerase (PGI), fructose-6-phosphate epimerase (F6PE), and tagatose-6-phosphate phosphatase (T6PP) to prepare tagatose; (ii) PGI, piscose-6-phosphate epimerase (P6PE), and picose-6-phosphate phosphatase (P6PP) to prepare allulose; (iii) PGI, P6PE, allose-6-phosphate isomerase (A6PI), and allose-6-phosphate phosphatase (A6PP) to prepare allose; (iv) PGI, mannose-6-phosphate isomerase (M6PI) or phosphoglucose/phosphomannose isomerase (PGPMI), and mannose 6-phosphate phosphatase (M6PP) to prepare mannose; (v) PGI, F6PE, galacto
• the immobilized enzyme compositions can also optionally contain 4-glucan transferase (4GT).
• 4GT can be used to increase hexose yields by recycling the degradation products glucose, maltose, and maltotriose into longer maltooligosaccharides; which can be phosphorolytically cleaved by aGP to yield G1P.
• the relative weight ratios between enzymes in an immobilized enzyme composition of the invention may range from 1:1000 to 1000:1, from 1:100 to 100:1 or from 1:50 to 50:1, when comparing any two enzymes in the immobilized composition.
• the enzyme ratios including other optional enzymes discussed below, can be varied to increase the efficiency of hexose production.
• a particular enzyme may be present in an amount about 2x, 3x, 4x, 5x, lOx etc. relative to the amount of another enzyme.
• Relative weight/weight ratios among the enzymes in an immobilized enzyme composition of the invention can be optimized to increase process performance and/or hexose yield.
• the weight of each enzyme in an immobilized enzyme composition, relative to the total weight of the enzymes (w/w)% ranges from 0.1% to 70%.
• some immobilized enzyme compositions of the invention contain 10-30% (aGP); 10-30% (PGM); and when present 0.1-10% (PGI) and 0.1-10%
• an immobillized enzyme composition of the invention that can be used for the production of tagatose, the weight of each enzyme relative to the total weight of the enzymes (w/w)% is: 10-30% (aGP); 0-10% (4GT); 10-30% (PGM); 0.1-10% (PGI); 15-35% (F6PE); and T6PP (25-45%), wherein the total weight of enzymes in the composition is 100 w/w% relative to the total weight of the enzymes.
• Some immobilized enzyme compositions of the invention for use in tagatose production contain: 19% aGP; 3% 4GT; 17% PGM; 3% PGI; 23% F6PE; and T6PP 35%, wherein the % weight of each enzyme is relative to the total weight of the enzymes in the immobilized enzyme composition of the invention, and the total weight of enzymes in the composition is 100 w/w% relative to the total weight of the enzymes.
• an immobillized enzyme composition of the invention for used for the production of allulose in which the weight of each enzyme relative to the total weight of the enzymes (w/w)% is: 10-30% (aGP); 0-10% (4GT); 10-30% (PGM); 0.1-10% (PGI); 0.1- 10% (P6PE); and (45-65%) P6PP, wherein the total weight of enzymes in the composition total 100 w/w% relative to the total weight of the enzymes.
• Some immobilized enzyme compositions of the invention for use in allulose production contain: 20% aGP; 3% 4GT; 16.5% PGM; 3% PGI; 3% P6PE; and P6PP 54%, wherein the % weight of each enzyme is relative to the total weight of the enzymes in the immobilized enzyme composition of the invention, and the total weight of enzymes in the composition is 100 w/w% relative to the total weight of the enzymes.
• enzymes contained in immobilized compositions of the invention are generally referred to based on the reactions they catalyze, (i.e., by specificity and function), enzymes are also commonly identified by amino acid sequence, (e.g., a SEQ. ID. NO.; a database indentification number, such as a UniProt ID), amino acid sequence identity/similarity to an enzyme of known function, nucleotide sequence, or nucleotide sequence identity/similarity to an enzyme of known function.
• amino acid sequence e.g., a SEQ. ID. NO.; a database indentification number, such as a UniProt ID
• Enzymes known in the art and used to prepare hexoses may be used in an immobilized enzyme composition of the invention, including immobilized enzyme compositions that can be used to produce , tagatose, psicose, fructose, allose, mannose, galactose, altrose, talose, sorbose, gulose, idose, and inositol.
• immobilized enzyme compositions that can be used to produce , tagatose, psicose, fructose, allose, mannose, galactose, altrose, talose, sorbose, gulose, idose, and inositol.
• Exemplary enzymes known in the art may be used in a immoblized enzyme composition of the invention are identified below with a relevant patent document. The disclosure of the enzymes in the listed patents is specifically incorporated here by reference.
• the amino acid sequences of enzymes contained in immobilized enzyme compositions of the invention also include enzymes, which may have been modified for any reason, such as, for example, to improve activity, stability (i.e., half-life), or yield.
• modified enzymes include, for example, fragments of enzymes, amino acid substitutions, and chimeric proteins.
• Modified enzymes includes variants of any enzyme disclosed herein. Variants may contain amino acid substitutions at one or more amino acid residues.
• a variant includes no more than 15, no more than 12, no more than 10, no more than 9, no more than 8, no more than 7, no more than 6, no more than 5, no more than 4, no more than 3, no more than 2 or no more than 1 conservative amino acid substitution relative to a naturally occurring enzyme and/or no more than 5, no more than 4, no more than 3, or no more than 2 non conservative amino acid substitutions, or no more than 1 non-conservative amino acid substitution, relative to a naturally occurring enzymes.
• a conservative amino acid substitution is one in which the amino acid residue is replaced with an amino acid residue having a similar side chain. Families of amino acid residues having similar side chains have been defined in the art.
• amino acids with basic side chains e.g., lysine, arginine, histidine
• acidic side chains e.g., aspartic acid, glutamic acid
• uncharged polar side chains e.g., glycine, asparagine, glutamine, serine, threonine, tyrosine, cysteine
• nonpolar side chains e.g., alanine, valine, leucine, isoleucine, proline, phenylalanine, methionine, tryptophan
• beta-branched side chains e.g., threonine, valine, isoleucine
• aromatic side chains e.g., tyrosine, phenylalanine, tryptophan
• Variant enzymes of the invention may include amino acid substitutions with amino acid analogs as well as amino acids, as described herein.
• An enzyme contained in an enzyme composition of the invention can also be an enzyme, which: i) shares at least 35% sequence identity with the amino acid sequence of an enzyme disclosed herein; and ii) can catalyze the same reaction of that particular disclosed enzyme with the necessary specificity for the process.
• an enzyme in a composition of the invention includes enzymes with amino acid sequences that are at least 35%, 36%, 37%, 38%, 39%, 40%, 41%, 42%, 43%, 44%, 45%, 46%, 47%, 48%, 49%, 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59%, 60%, 61%, 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89% 90% 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99% sequence identity with the amino acid sequence of an enzyme disclosed herein.
• sequence identity refers to the similarity between two, or more, amino acid or nucleic acid sequences. Sequence identity is typically measured in terms of percentage identity (or similarity or homology) between amino acid sequences; the higher the percentage, the more similar to each other are the compared sequences.
• enzyme compositions of the invention are immobilized to at least one carrier.
• a carrier may also be generally referred to herein as a "carrier material", “carrier resin”, or a “carrier bead”.
• multiple different carriers may be used to immobilize one or more enzymes. While carriers in immobilized enzyme compositions of the invention are not necessarily limited to a particular material, in some immobilized enzyme compositions of the invention, the carrier is a weak base ion exchange resin, which may, optionally, be composed of phenol formaldehyde, (i.e., a phenol formaldehyde polycondensate).
• the carrier material is based on controlled pore glass (CPG) particles or hybrid CPG particles (WO2015115993A1).
• CPG controlled pore glass
• WO2015115993A1 hybrid CPG particles
• the carriers in some immobilized enzyme compositions of the invention are functionalized by the inclusion of a tertiary amine group, while in others, a secondary amine group provides functionality.
• a carrier resin is functionalized with groups used to chelate a metal, such as, for example, iron or zinc.
• the chelated metal groups allow high affinity binding of molecules via appropriate binding group, such as, for example, a Histidine (His)-tag.
• appropriate binding group such as, for example, a Histidine (His)-tag. Examples of such functional groups are found in
• WO2015115993A1 and Cassimjee et al. A general protein purification and immobilization method on controlled porosity glass: biocatalytic applications. Chem. Commun., 2014, 50, 9134; including but not limiting to 2,4-dihydroxybenzyl residues.
• the carriers in some immobilized enzyme compositions of the invention possess two or more of the various carrier features that are listed above.
• the enzyme compositions of any of the immobilized enzyme compositions described, herein, for use in processes for converting starches and starch derivatives and saccharides to hexose monosaccharides including processes for producing tagatose, psicose, fructose, allose, mannose, galactose, altrose, talose, sorbose, gulose, idose, or inositol, are immobilized to a weak base anion exchange resin; which may, or may not be composed of phenol formaldehyde
• a carrier resin with the foregoing features is sold commercially as DUOLITETM PWA7.
• the enzyme compositions of any of the immobilized enzyme compositions described, herein, for use in processes converting starches and starch derivatives and saccharides to hexose monosaccharides, including processes for producing tagatose, psicose, fructose, allose, mannose, galactose, altrose, talose, sorbose, gulose, idose, or inositol are immobilized to a His- tag affinity resin; which may, or may not be composed of a CPG or hybrid CPG particle material carrier; and which may, or may not chelate iron or zinc.
• a carrier resin with the foregoing features is sold commercially as EziGTM Opal.
• the total weight of the enzymes in an immobilized enzyme composition of the invention range from 2.5%-12.5%. Therefore, the total weight of the enzyme compositions of any of the immobilized enzyme compositions described, herein, for use in processes converting starches and starch derivatives and saccharides to hexose
• monosaccharides including processes for producing tagatose, psicose, fructose, allose, mannose, galactose, altrose, talose, sorbose, gulose, idose, or inositol, relative to the weight of the carrier (w/w)%, can be about 2.5%, 3%, 3.5%, 4%, 4.5%, 5%, 5.5%, 6%, 6.5%, 7%, 7.5%, 8%, 8.5%, 9%, 9.5%,
• the total weight of the enzymes, (aGP, PGM, PGI, F6PE, and T6PP) or (aGP, 4GT, PGM, PGI, F6PE, and T6PP) in some immobilized enzyme compositions used to produce tagatose is 5%, while in the total weight of the enzymes (aGP, PGM, PGI, P6PE, and P6PP) or (aGP, 4GT, PGM, PGI, P6PE, and P6PP) is 6.5%.
• the invention also relates to an enzymatic process for preparing a hexose from a saccharide comprising the step of contacting a starch derivative with an immobilized enzyme composition of the invention under suitable reaction conditions to convert the starch derivative to the hexose.
• the at least two, at least three, at least four, at least five, at least six carriers, at least seven, or at least eight enzymes of a process may be immobilized on the same carrier, or immobilized on multiple carriers.
• the enzymes may be immobilized on the same carrier, or the immobilized enzymes may be disricited among at least two, at least three, at least four, at least five, at least six carriers, at least seven, or at least eight carriers, which may be the same type of carrier, or any combination of different carriers and immobilization methodolgies, including weak base anion exchange resin carriers, phenol formaldehyde polycondensate carriers, carriers that a comprise tertiary amine functional group, ( e.g ., DUOLITETM A568), carriers that comprise a secondary amine functional groups,
• carriers that comprise a His-tag affinity resin e.g ., DUOLITETM PWA7
• carriers that comprise a His-tag affinity resin e.g ., DUOLITETM PWA7
• carriers that comprise a His-tag affinity resin e.g ., DUOLITETM PWA7
• carriers that comprise controlled pore glass (CPG) particles e.g., EDOLITETM PWA7
• carriers that comprise a His-tag affinity resin e.g ., carriers that comprise controlled pore glass (CPG) particles
• carriers functionalized by a chelated metal including carriers in which the chelated metal is iron or zinc ⁇ e.g., EziGTM Opal).
• immobilized enzyme compositions of the invention can be used to produce tagatose, psicose, fructose, allose, mannose, galactose, altrose, talose, sorbose, gulose, idose, or inositol from starches and starch derivatives and saccharides under the reaction conditions described in published PCT applications WO 2018/169957, WO 2017/059278, and WO 2018/112139.
• the multiple catalyzation reaction steps in a process of producing a hexose using an immobilized enzyme composition of the invention can be conducted in a single bioreactor, or in a plurality of bioreactors that are arranged in series, or a reaction vessel.
• the steps can also be conducted in a plurality of bioreactors, or reaction vessels, that are arranged in series or parallel. All aforementioned processes can be run in batch mode or continuous mode. A "one-pot" process in a single bioreactor is preferred.
• the steps in an ezymatic processes of the invention can be conducted at a temperature ranging from about 35 ° C to about 90 ° C, about 40 ° C to about 70 ° C, about 50 ° C to about 60 ° C or about 55 ° C and at a pH ranging from about 5.0 to about 8.0, about 6.5 to about 7.5 or about 7.0 to about 7.5. They may be conducted for about 0.5 hours to about 48 hours, about 4 hours to 24 hours or about 8 hours to 12 hours.
• the enzymatic process steps of the inventions may be conducted ATP-free and/or NAD(P)(H)-free.
• the steps can be carried out at a phosphate concentration ranging from about 0.1 mM to about 150 mM.
• the phosphate used in the phosphorylation and dephosphorylation steps of the processes according to the inventions can be recycled within the enzymatic cascade reaction.
• the processes of the invention can be carried out in a packed column or in a slurry.
• reaction phosphate concentrations in each of the processes can range from about 0.1 mM to about 300 mM, from about 0 mM to about 150 mM, from about 1 mM to about 50 mM, preferably from about 5 mM to about 50 mM, or more preferably from about 10 mM to about 50 mM.
• the reaction phosphate concentration in each of the porcesses can be about 0.1 mM, about 0.5 mM, about 1 mM, about 1.5 mM, about 2 mM, about 2.5 mM, about 5 mM, about 6 mM, about 7 mM, about 8 mM, about 9 mM, about 10 mM, about 15 mM, about 20 mM, about 25 mM, about 30 mM, about 35 mM, about 40 mM, about 45 mM, about 50 mM, or about 55 mM.
• each of the processes disclosed herein can be conducted without added ATP as a source of phosphate, i.e., ATP-free.
• Each of the processes can also be conducted without having to add NAD(P)(H), i.e., NAD(P)(H)-free.
• Other advantages also include the fact that at least one step of the disclosed processes for making a hexose involves a highly energetically favorable chemical reaction which is essential for high yields.
• a highly energetically favorable chemical reaction for a process of the invention has an equilibrium constant (K eq ) of at least 2, at least 3, or at least 4.
• the starch derivatives can be prepared by enzymatic hydrolysis of starch or by acid hydrolysis of starch. See, for example, WO 2017/059278.
• the enzymatic hydrolysis of starch can be catalyzed or enhanced by isoamylase (IA, EC.
• cellulose can be prepared by enzymatic hydrolysis of cellulose catalyzed by cellulase mixtures, by acids, or by pretreatment of biomass.
• Example 1 Evaluation of enzyme carriers. Enzyme carriers were evaluated for relative reaction rates of enzyme compositions for producing tagatose, as well as for their effect on enzyme stability. With those objectives in mind, the following enzyme carrier materials were evaluated: Four branded phenol-formaldehyde matrix resins (DUOLITETM A568, DUOLITETM A561, DUOLITETM PWA7, AmberLiteTM FPA54); Two branded polystyrene resins (LifetechTM ECR1640 and LifeTechTM ECR1504); Two branded polymethylacrylate resins (LifetechTM ECR8309M and ChromoliteTM D6154); and a branded controlled pore glass resin (EziG OpalTM).
• DUOLITETM A568, DUOLITETM A561, DUOLITETM PWA7, AmberLiteTM FPA54 Two branded polystyrene resins (LifetechTM ECR1640 and LifeTechTM ECR1504)
• Two branded polymethylacrylate resins LifetechTM ECR8309M and
• DUOLITETM A568 DuPont Ion Exchange Resin is a highly porous, granular, weak base anion exchange resin based on crosslinked phenol-formaldehyde polycondensate. Its hydrophilicity and controlled pore size distribution make it the most suitable resin to be used as an enzyme carrier in many bioprocessing applications.
• the ionic strength, pore volume, pore size, and particle size of DUOLITETM A568 are designed for optimum immobilization of enzymes used in the starch and fat (and other) industries.
• DUOLITETM A561 Ion Exchange Resin is a weak basic anion exchanger made from phenol formaldehyde with a tertiary amine functional group, and its broad specifications are similar to DUOLITETM A568 resin, but DUOLITETM A561 has a different bead morphology.
• DUOLITETM PWA7 is a weakly basic anion exchanger with amine functionality, and salt form.
• AMBERLITETM FPA54 Ion Exchange Resin is a highly porous, weak base, anion exchange resin, based on a crosslinked phenol-formaldehyde matrix.
• the low-swelling characteristics of AMBERLITETM FPA54 give it excellent osmotic and physical stability resulting in less product loss and longer product life than conventional styrenic resins in food processing and bioprocessing applications.
• the hydrophilic phenolic, porous matrix of AM BERLITETM FPA54 permits the reversible adsorption of high molecular weight, organic, color bodies frequently found in solutions of natural product and fermentation products.
• AM BERLITETM FPA54 exhibits a high selectivity for sulfates and phosphates and, therefore, makes it ideal for the treatment of both citric and lactic acids derived from fermentation where it has a long history of use, particularly due to its excellent osmotic stability.
• LifetechTM ECR1640 is a copolymer of divinylbenzene (DVB) and styerene functionalised with quaternary amines. It is used for enzyme immobilization by ionic interaction of the ionizable surface aminoacids (Lys, Arg, His, Asp, Glu) with the tertiary amines on the polymer. It is particularly suitable for immobilization of enzymes with pis in the range 3-5 like many glycosidases. LifetechTM ECR1640 main features are the possibility to regenerate the resin, pH adjustment before immobilization and large particle size for column applications. DVB/styerene with quaternary amines, 300-1200 micron, pH stability 1-14, supplied wet (66-72% water), capacity 0.85 eq/l Cl- form.
• DVB/styerene with quaternary amines 300-1200 micron, pH stability 1-14, supplied wet (66-72% water), capacity 0.85 eq/l Cl-
• LifetechTM ECR1504 is a copolymer of divinylbenzene (DVB) and styerene functionalised with tertiary amines. It is used for enzyme immobilization by ionic interaction of the ionizable surface aminoacids (Lys, Arg, His, Asp, Glu) with the tertiary amines on the polymer. It is particularly suitable for immobilization of enzymes with pi in the range 3-5 like many glycosidaseses. LifetechTM ECR1504 main features are possibility to regenerate the resin, pH adjustment before immobilization and large particle size for column applications. DVB/styerene with tertiary amines, 300-1200 micron, pH stability 1-14, supplied wet (53-62% water), capacity 1.3 eq/l free base.
• DVB/styerene with tertiary amines 300-1200 micron, pH stability 1-14, supplied wet (53-62% water), capacity 1.3 eq/l free base
• LifetechTM ECR8309M is a hydrophilic, high porosity, methacrylate polymer functionalized with amino groups on a short spacer (C2).
• ChromoliteTM D6154 is macroporous polymethacrylate is a material, funtionalized for affinity binding specific for poly His-tags.
• the functional group is iminodiacetic, Na + form
• EziGTM Opal is made from controlled pore glass (CPG) particles, and has a hydrophilic surface. The material has a narrow pore size distribution, produced with a pore diameter of ⁇ 500 A as standard. A mass loading of 15 - 60% active enzyme is expected. Other variations of EziGTM exist and were tested (Amber and Coral), but they performed suboptimally compared to Opal.
• CPG controlled pore glass
• An enzyme composition containing the following weight/weight (w/w) percentages of each of the following enzymes, respectively, relative to to the total composition enzyme weight: 19% a-glucan phosphorylase (aGP, U N IPROT I D G8NCC0, SEQ. I D. NO. 1); 17% Phosphoglucomutase (PGM, U N I PROT ID A0A0P6YKY9, SEQ. I D. NO. 2); 3% phosphoglucoisomerase (PGI, U N IPROT I D Q5SLL6, SEQ. I D. NO.
• the carrier Prior to adhering the enzymes in the composition to each carrier, the carrier was equilibrated with two equivalent volumes of water, and then three equivalent volumes of immobilization buffer pH 7.2 (5 mM Na PC> , 5 mM MgS , 0.25 mM MnC ). The enzymes were suspended in the immobilization buffer to form the enzyme composition (preferably between 5 and 10 g/L enzyme) which was then added to the carrier to make a slurry.
• the absorbance of the enzyme composition and carrier slurry was measured at 280 nm to track the adsorbtion of the enzymes to the carrier until >95% of the soluble enzymes were no longer suspended in solution, which was around 6 hrs for a 5% (w/w, enzymes/carrier) loaded sample.
• the supernatant was removed and immobilized carrier washed with reaction buffer pH 7.2 (25 mM Na PC> , 4 mM Na SC> , 2.5 mM MgS , 0.25 mM MnC ) to remove any remaining soluble enzymes.
• Each slurry sample was mixed with an equal volume of a 2X concentrated feed solution (320 g/L maltodextrin dextrose equivalent 5 (DE 5) pH 7.2, 25 mM Na PC> , 4 mM Na SC> , 2.5 mM MgS , 0.25 mM MnC ) to achieve a final maltodextrin substrate concentration of 160 g/L in reaction conditions.
• the maltodextrin - carrier mixture was shaken overnight in a 2.0 mL microfuge tube in an Eppendorf Thermomixer F2.0 at 800- 1500 rpm, and at either 50°C for the DUOLITETM A568, LifetechTM ECR1640, LifeTechTM ECR1504,
• Immobilized enzyme composition cascade activity rates (pmol of tagatose produced/min/mg of total enzyme) were calculated for each carrier. Cascade activity rates for each carrier-composition preparation are reported in Table 1 relative to the cascade activity rate of the Duolite A568 carrier-composition preparation. Remaining maltodextrin and tagatose were washed off each immobilized enzyme preparation by five washes, each consisting of at least three volume equivalents of reaction buffer to equilibrate the preparation for re-use. The immobilized enzyme preparations were re-used by adding 2X concentrated maltodextrin feed solution as before. Reaction rates were calculated with each subsequent use and plotted to ascertain the working half-life of the immobilized catalyst.
• the half-life was determined by measuring the cascade rate (pmol/min/mg) on Day 0 and subsequent days until less than half the activity was lost consistently (compared to Day 0).
• a designation of n/d in Table 3 indicates ⁇ 10% of the half-life was found or the cascade activity was ⁇ 50% of Duolite A568.
• Example 2 Effect of enzyme ratio on cascade rate.
• the amounts of aGP, PGM, PGI, F6PE, T6PP, and 4-GT immobilized on DUOLITETM A568 were varied relative to the DUOLITETM A568- immobilized composition that was prepared using the enzyme ratios described in Example 1 and Table 1 ("the Example 1 immobilized composition"), in two, immobilized composition preparations. Their activity rates were evaluated against the performance of the Example 1 immobilized composition.
• the amounts of the enzymes were based on the observed rate of each enzyme relative to T6PP in solution, as shown in Table 4 (Fig.
• Example 3 Effect of distribution of enzymes on one or more carriers.
• Example 4 Effect of enzyme loading. Enzymes at different loadings (g enzymes / g carrier ranging from 2.5% to 12.5% in 2.5% intervals) were immobilized on Duolite A568 as described in Example 1 and in the ratios listed in Table 2. Unlike Example 1, however, the immobilizations were allowed to continue for 16 hrs for each sample instead of 6 hrs to allow time for binding of enzymes to reach completion for the higher loadings. Soluble enzymes were washed off with five washes containing at least three sample volumes of reaction buffer pH 7.2 (25 mM Na2P04, 4 mM Na2S03, 2.5 mM MgSC , 0.25 mM MnC ).
• Example 2 The samples were reacted with maltodextrin feed solution for 16 hours and conversion rates measured in pmol/min/mg total enzymes as in Example 1.
• the relative enzymatic cascade rates with respect to a 5% loaded sample are plotted as a function of loading in Figure 2.
• the loading response together with the price of enzymes and support allows design of the most cost efficient catalyst.
• Example 5 Allulose preparation using an immobilized enzyme composition. Enzyme compositions containing the following enzymes, aGP, PGM, PGI, psicose 6-phosphate 3-epimerase (P6PE), psicose 6-phosphate phosphatase (P6PP), and 4-GT in three different ratios among the enzymes were immoblized to DUOLITETM A568 in respective immobilization reactions, as described in Table 6. A comparative analysis of the three immobilized composition preparations to produce allulose from maltodextrin was performed.
• DUOLITETM A568 was pretreated a 1% aqueous solution of glutaraldehyde (GA) for 2 hours at room temperature in an end-over-end rotator.
• the GA was removed by washing 5x with water and 2x conditioning washes with immobilization buffer (10 mM sodium phosphate buffer pH 7.2, 5 mM MgS04, and 80 mM C0CI2).
• immobilization buffer (10 mM sodium phosphate buffer pH 7.2, 5 mM MgS04, and 80 mM C0CI2).
• Enzyme solutions Table 5 were then added to the GA-pretreated carrier after the final wash step (supernatant discarded).
• the enzyme solutions consisted of 5 g/L enzyme in reaction buffer (10 mM sodium phosphate buffer pH 7.2, 5 mM MgSC>4, 5 mM NaSC>3, and 80 pM C0CI2).
• the enzyme plus carrier solutions were incubated at room temperature for 16 hours on an orbital shaker set at 800 rpm to immobilize the enzyme mixtures in the carrier.
• the total percent loading was 6.5% (mg of enzyme per mg of carrier).
• the supernatant was washed off with six washes consisting of reaction buffer to remove any remaining non-bound enzymes. The final supernatant was removed and 150 g/L maltodextrin, previously dissolved in reaction buffer was added.
• the maltodextrin - carrier mixture was shaken overnight (15-16 hours) in a 2.0 mL microfuge tube in an Eppendorf Thermomixer F2.0 at 800 - 1500 rpm and 55 °C.
• the resulting product was developed on a SupelCogel Pb column (Sigma Aldrich) using an Agilent 1100 series HPLC system with in-line refractive index detector (0.6 mL/min with ultrapure water mobile phase at 80°C). Allulose concentrations were determined by comparing sample peak areas to those of known allulose standard solutions, and enzymatic cascade specific activity rates calculated.
• the allulose production reaction was washed off each immobilization preparation with 4x washes of reaction buffer to equilibrate the immobilized preparation for re-use. The results of each sample composition's relative specific activities are shown below in Table 7.
• Example 6 Allose preparation from maltodextrin using an immobilized enzyme composition. Allose will be produced from maltodextrin using an immobilized enzyme composition that includes aGP, PGM, PGI, 4GT and P6PE, A6PI, and A6PP.
• Example 7 Fructose preparation from maltodextrin using an immobilized enzyme
• Fructose will be produced from maltodextrin using an immobilized enzyme composition that includes aGP, PGM, PGI, 4GT, and F6PP.
• Example 8 Mannose preparation from maltodextrin using an immobilized enzyme composition.
• Fructose will be produced from maltodextrin using an immobilized enzyme composition that includes aGP, PGM, PGI, 4GT, and M6PI or PGPMI and M6PP.
• Example 9 Galactose preparation from maltodextrin using an immobilized enzyme composition.
• Galactose will be produced from maltodextrin using an immobilized enzyme composition that includes aGP, PGM, PGI, F6PE, 4GT, Gal6PI and Gal6P.
• Example 10 Altrose preparation from maltodextrin using an immobilized enzyme composition.
• Altrose will be produced from maltodextrin using an immobilized enzyme composition that includes aGP, PGM, PGI, P6PE, Alt6PI, and Alt6PP.
• Example 11 Talose preparation from maltodextrin using an immobilized enzyme composition. Talose will be produced from maltodextrin using an immobilized enzyme composition that includes aGP, PGM, PGI, F6PE, Tal6PI, and Tal6PP.
• Example 12 Sorbose preparation from maltodextrin using an immobilized enzyme composition. Sorbose will be produced from maltodextrin using an immobilized enzyme composition that includes aGP, PGM, PGI, F6PE, S6PE, and S6PP.
• Example 13 Gulose preparation from maltodextrin using an immobilized enzyme composition. Gulose will be produced from maltodextrin using an immobilized enzyme composition that includes aGP, PGM, PGI, F6PE, S6PE, Gul6PI, and Gul6PP.
• Example 15 Idose preparation from maltodextrin using an immobilized enzyme composition. Idose will be produced from maltodextrin using an immobilized enzyme composition that includes aGP, PGM, PGI, F6PE, S6PE, I6PI, and I6PP.
• Example 16 Inositol preparation from maltodextrin using an immobilized enzyme composition. Inositol will be produced from maltodextrin using an immobilized enzyme composition that includes aGP, PGM, 4GT, IPS, and IMP.

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Life Sciences & Earth Sciences (AREA)
• Health & Medical Sciences (AREA)
• Engineering & Computer Science (AREA)
• Zoology (AREA)
• Wood Science & Technology (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Genetics & Genomics (AREA)
• General Health & Medical Sciences (AREA)
• General Engineering & Computer Science (AREA)
• Biochemistry (AREA)
• Microbiology (AREA)
• Biotechnology (AREA)
• Biomedical Technology (AREA)
• Molecular Biology (AREA)
• Medicinal Chemistry (AREA)
• General Chemical & Material Sciences (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Inorganic Chemistry (AREA)
• Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
• Preparation Of Compounds By Using Micro-Organisms (AREA)
• Enzymes And Modification Thereof (AREA)

Priority Applications (9)

Applications Claiming Priority (4)

Publications (1)

Family

ID=74209943

Family Applications (1)

Country Status (10)

Cited By (3)

Citations (10)

Family Cites Families (4)

• 2020
  • 2020-07-17 CN CN202080065138.3A patent/CN114599786A/zh active Pending
  • 2020-07-17 BR BR112022000699A patent/BR112022000699A2/pt unknown
  • 2020-07-17 EP EP20841623.0A patent/EP3999636A4/en active Pending
  • 2020-07-17 KR KR1020227005195A patent/KR20220035460A/ko unknown
  • 2020-07-17 WO PCT/US2020/042562 patent/WO2021011881A1/en unknown
  • 2020-07-17 CA CA3143852A patent/CA3143852A1/en active Pending
  • 2020-07-17 US US17/627,488 patent/US20220259628A1/en active Pending
  • 2020-07-17 MX MX2022000381A patent/MX2022000381A/es unknown
  • 2020-07-17 JP JP2022502510A patent/JP2022541471A/ja active Pending
• 2022
  • 2022-02-10 CO CONC2022/0001348A patent/CO2022001348A2/es unknown

Patent Citations (10)

Also Published As

Similar Documents

Legal Events